Amneal Pharmaceuticals Inc (AMRX)

Date: O: H: L: C: Vol:

Amneal Pharmaceuticals Inc (AMRX) 財務データ

*すべての数値は百万単位です

期間終了日	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	10.20%796.20	722.52	814.32	784.51	724.51
Cost Of Revenue	14.73%461.69	402.41	517.13	510.54	438.26
Gross Profit	4.50%334.51	320.11	297.19	273.97	286.25
	7.10%148.72	138.86	-	-	-
Selling, General, and Administrative	7.10%148.72	138.86	-	-	-
Research and Development	1.65%39.02	38.38	-	-	-
Operating Income/Loss	8.47%129.77	141.77	112.03	70.34	111.37
Nonoperating Income/Loss	4.57%-58.78	-61.60	-56.80	-75.57	-59.66
Income/Loss From Continuing Operations Before Tax	11.46%70.99	80.18	55.24	-5.22	51.71
Income Tax Expense/Benefit	36.76%1.38	2.18	5.66	-23.36	16.10
	10.75%69.61	78.00	49.57	18.13	35.61
Attributable To Parent	7.38%57.66	62.26	35.08	2.37	22.42
Available To Common Stockholders, Basic	7.38%57.66	62.26	35.08	2.37	22.42
Attributable To Noncontrolling Interest	24.09%11.95	15.74	14.50	15.76	13.19
Basic Average Shares	1.01%319.20	316.02	0.37	314.17	313.74
Diluted Average Shares	0.25%328.10	328.93	1.10	324.75	322.36
Basic Earnings Per Share	10.00%0.18	0.20	0.11	0.01	0.07
Diluted Earnings Per Share	5.26%0.18	0.19	0.11	0.01	0.07